Synergy CHC Corp
SNYR1.830USD
+0.030+1.67%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
20.59MMarket Cap
6.50P/E TTM
More Details of Synergy CHC Corp Company
Synergy CHC Corp. is a provider of consumer healthcare, beauty, and lifestyle products. The Company's brand portfolio includes FOCUSfactor and Flat Tummy. FOCUSfactor is a clinically studied brain health supplement and functional beverage line. Flat Tummy is a lifestyle brand that provides a suite of nutritional products to help women achieve their weight management goals. It has six additional, non-core brands are Hand MD is a complete hand-care brand to help maintain clean and healthy hands while reducing the signs of aging; Perfekt Beauty is in beauty line of products for the eyes, lips, brows, cheeks and skin; Sneaky Vaunt is in lingerie brand with a line of women’s shapewear, bralettes and panties; The Queen Pegasus is in eyelash enhancement products for longer, thicker, natural lashes; Neuragen is in fast-acting topical treatments for neuropathic (nerve) pain, and UrgentRx is in line of fast-acting, portable, powdered over-the-counter medications.
Synergy CHC Corp Info
Ticker SymbolSNYR
Company nameSynergy CHC Corp
IPO dateNov 08, 2013
CEORoss (Jack)
Number of employees21
Security typeOrdinary Share
Fiscal year-endNov 08
Address865 Spring St
CityWESTBROOK
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code04092-3828
Phone16159399004
Websitehttps://synergychc.com/
Ticker SymbolSNYR
IPO dateNov 08, 2013
CEORoss (Jack)
Company Executives of Synergy CHC Corp
Name
Name/Position
Position
Shareholding
Change
Mr. Jack Ross
Mr. Jack Ross
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
674.81K
+1.67%
Mr. Nitin Kaushal, CPA
Mr. Nitin Kaushal, CPA
Independent Director
Independent Director
--
--
Mr. J. Paul SoRelle
Mr. J. Paul SoRelle
Independent Director
Independent Director
--
--
Mr. Alfred Baumeler
Mr. Alfred Baumeler
President, Director
President, Director
--
--
Ms. Jaime Fickett
Ms. Jaime Fickett
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Teresa Thompson
Ms. Teresa Thompson
Director
Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Jack Ross
Mr. Jack Ross
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
674.81K
+1.67%
Mr. Nitin Kaushal, CPA
Mr. Nitin Kaushal, CPA
Independent Director
Independent Director
--
--
Mr. J. Paul SoRelle
Mr. J. Paul SoRelle
Independent Director
Independent Director
--
--
Mr. Alfred Baumeler
Mr. Alfred Baumeler
President, Director
President, Director
--
--
Ms. Jaime Fickett
Ms. Jaime Fickett
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Teresa Thompson
Ms. Teresa Thompson
Director
Director
--
--
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2023
FY2023Q3
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Nutraceuticals
6.73M
82.79%
Consumer Goods
1.40M
17.21%
By RegionUSD
Name
Revenue
Proportion
United States
7.95M
97.78%
Foreign countries
180.67K
2.22%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Nutraceuticals
6.73M
82.79%
Consumer Goods
1.40M
17.21%
Shareholding Stats
Updated: Mon, Nov 17
Updated: Mon, Nov 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Gowan Private Equity, Inc.
32.70%
Knight Therapeutics (Barbados), Inc.
13.18%
Ross (Jack)
6.00%
Gratia Capital, LLC
4.93%
Heartland Advisors, Inc.
4.89%
Other
38.31%
Shareholders
Shareholders
Proportion
Gowan Private Equity, Inc.
32.70%
Knight Therapeutics (Barbados), Inc.
13.18%
Ross (Jack)
6.00%
Gratia Capital, LLC
4.93%
Heartland Advisors, Inc.
4.89%
Other
38.31%
Shareholder Types
Shareholders
Proportion
Corporation
49.49%
Individual Investor
6.97%
Hedge Fund
5.23%
Investment Advisor/Hedge Fund
5.13%
Investment Advisor
4.07%
Research Firm
0.14%
Other
28.97%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
15
489.86K
4.38%
-692.44K
2025Q2
20
7.35M
81.54%
-158.23K
2025Q1
20
7.51M
86.32%
+3.84M
2024Q4
17
7.37M
84.73%
+5.72M
2024Q3
6
504.50K
6.68%
-5.50M
2024Q2
6
6.00M
79.48%
+6.00M
2023Q3
6
5.96M
78.91%
--
2023Q2
6
5.96M
78.91%
--
2023Q1
6
5.96M
78.91%
--
2022Q4
6
5.96M
78.91%
--
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Gowan Private Equity, Inc.
3.68M
32.87%
--
--
Apr 21, 2025
Knight Therapeutics (Barbados), Inc.
1.48M
13.25%
--
--
Jun 11, 2025
Ross (Jack)
674.81K
6.03%
+11.10K
+1.67%
Jul 30, 2025
Gratia Capital, LLC
--
0%
-105.94K
-100.00%
Jun 30, 2025
Sanders Morris LLC
391.70K
3.5%
+18.70K
+5.01%
Sep 30, 2025
Dunhill Distribution Group, Inc.
269.63K
2.41%
--
--
Apr 21, 2025
Gowan Capital, Inc.
136.56K
1.22%
--
--
Apr 21, 2025
SoRelle (James Paul)
108.96K
0.97%
--
--
Apr 21, 2025
The Vanguard Group, Inc.
22.13K
0.2%
--
--
Jun 30, 2025
View more
Related ETFs
Updated: Tue, Dec 2
Updated: Tue, Dec 2
Name
Proportion
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Synergy CHC Corp?
The top five shareholders of Synergy CHC Corp are:
Gowan Private Equity, Inc. holds 3.68M shares, accounting for 32.87% of the total shares.
Knight Therapeutics (Barbados), Inc. holds 1.48M shares, accounting for 13.25% of the total shares.
Ross (Jack) holds 674.81K shares, accounting for 6.03% of the total shares.
Gratia Capital, LLC holds 0.00 shares, accounting for 0.00% of the total shares.
Sanders Morris LLC holds 391.70K shares, accounting for 3.50% of the total shares.
Gowan Private Equity, Inc. holds 3.68M shares, accounting for 32.87% of the total shares.
Knight Therapeutics (Barbados), Inc. holds 1.48M shares, accounting for 13.25% of the total shares.
Ross (Jack) holds 674.81K shares, accounting for 6.03% of the total shares.
Gratia Capital, LLC holds 0.00 shares, accounting for 0.00% of the total shares.
Sanders Morris LLC holds 391.70K shares, accounting for 3.50% of the total shares.
What are the top three shareholder types of Synergy CHC Corp?
The top three shareholder types of Synergy CHC Corp are:
Gowan Private Equity, Inc.
Knight Therapeutics (Barbados), Inc.
Ross (Jack)
Gowan Private Equity, Inc.
Knight Therapeutics (Barbados), Inc.
Ross (Jack)
How many institutions hold shares of Synergy CHC Corp (SNYR)?
As of 2025Q3, 15 institutions hold shares of Synergy CHC Corp, with a combined market value of approximately 489.86K, accounting for 4.38% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -77.17%.
What is the biggest source of revenue for Synergy CHC Corp?
In FY2025Q2, the Nutraceuticals business generated the highest revenue for Synergy CHC Corp, amounting to 6.73M and accounting for 82.79% of total revenue.
